SCM

Superstring Capital Management Portfolio holdings

AUM $187M
1-Year Est. Return 270.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+270.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$187M
AUM Growth
+$85.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$13.7M
2
+$6.85M
3
+$5.79M
4
DFTX
Definium Therapeutics
DFTX
+$5.26M
5
AXSM icon
Axsome Therapeutics
AXSM
+$5.23M

Top Sells

1
+$7.99M
2
+$5.65M
3
+$5.39M
4
BBIO icon
BridgeBio Pharma
BBIO
+$4.6M
5
SMMT icon
Summit Therapeutics
SMMT
+$4.08M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASMB icon
26
Assembly Biosciences
ASMB
$469M
$2.22M 1.19%
+65,273
ORIC icon
27
Oric Pharmaceuticals
ORIC
$1.35B
$2.09M 1.12%
255,370
+166,024
TARA icon
28
Protara Therapeutics
TARA
$320M
$1.92M 1.03%
360,000
TRVI icon
29
Trevi Therapeutics
TRVI
$1.61B
$1.86M 0.99%
+148,292
TYRA icon
30
Tyra Biosciences
TYRA
$1.74B
$1.54M 0.83%
+58,677
TVTX icon
31
Travere Therapeutics
TVTX
$2.64B
$1.45M 0.78%
38,022
-15,605
VRDN icon
32
Viridian Therapeutics
VRDN
$2.89B
$1.35M 0.72%
+43,230
RZLT icon
33
Rezolute
RZLT
$300M
$1.21M 0.65%
+513,765
DNTH icon
34
Dianthus Therapeutics
DNTH
$2.39B
$1.08M 0.58%
+26,249
SPRB
35
Spruce Biosciences, Inc. Common Stock
SPRB
$58M
$1.06M 0.57%
+12,137
AARD
36
Aardvark Therapeutics
AARD
$119M
$912K 0.49%
+69,496
GMAB icon
37
Genmab
GMAB
$18.3B
$898K 0.48%
+29,162
PALI icon
38
Palisade Bio
PALI
$270M
$863K 0.46%
+367,103
FULC icon
39
Fulcrum Therapeutics
FULC
$520M
$815K 0.44%
+72,060
RARE icon
40
Ultragenyx Pharmaceutical
RARE
$2.22B
$730K 0.39%
+31,738
PTN
41
Palatin Technologies
PTN
$38.2M
$522K 0.28%
+33,971
IVA
42
Inventiva
IVA
$1.3B
$465K 0.25%
+100,000
IPSC icon
43
Century Therapeutics
IPSC
$198M
$461K 0.25%
462,963
BMEA icon
44
Biomea Fusion
BMEA
$96.9M
$310K 0.17%
250,000
ENTX icon
45
Entera Bio
ENTX
$62.8M
$33.3K 0.02%
+17,142
BBIO icon
46
BridgeBio Pharma
BBIO
$12.7B
– –
-88,658
CRBP icon
47
Corbus Pharmaceuticals
CRBP
$147M
– –
-57,644
ETNB
48
DELISTED
89bio
ETNB
– –
-384,652
NBP
49
NovaBridge Biosciences American Depositary Shares
NBP
$398M
– –
-139,886
INSM icon
50
Insmed
INSM
$31.2B
– –
-19,786
1
2
3